This advert is not available!
A permanent position as Research Coordinator is available in the group of Professor Molly Stevens in the Division of Biomaterials at the Department of Medical Biochemistry and Biophysics (MBB). The successful applicant will join a multidisciplinary research team with a translational profile in biomaterials and tissue engineering, and should have expertise in developing and characterizing novel soft nanoparticle formulations for healthcare applications.
The lab of Molly Stevens is part of the Biomaterials division of MBB. For more information see www.stevensgroup.org and www.ki.se/mbb.
The successful candidate will be involved in leading and contributing to translational projects at the interface between materials science, chemistry and biology. The candidate will work on the development and characterization of composite materials with controlled architecture, composition and biological activity of a range of healthcare applications and lead related small angle scattering research projects. The research coordinator will be expected to undertake a role in the management of the group, internal and external academic and industrial collaborations and translational research projects, as well as in the research. Focus of the research activities will be in the field of soft matter applications for healthcare. In particular the role entails the design and characterization of a range of soft nanoparticle formulations, in particular lipid formulations, for diagnostic and drug delivery applications. The candidate will be offered extensive opportunities for collaborative work, both within KI and external to the group of Molly Stevens at Imperial College in London and other groups.
Key Responsibilities:
Experience and Knowledge:
Skills and Abilities:
The candidate must have a PhD and a previous post-doctoral experience in biomaterials, nanoscience, materials science, biology, an engineering discipline or other relevant discipline, and have experience in i) nanoparticle formulation methods and characterization, and their application in healthcare, ii) leading small angle scattering projects including beam time applications, experiment planning and execution, and developing models for data analysis, iii) a range of materials characterization techniques including EM and cryo-TEM, NTA, DLS, NMR, HPLC, iv) background in working in a chemical synthesis laboratory v) track record of leading research projects including mentoring students and successful grant applications. Excellent communication and organizational skills are necessary. A proven record of publications in top journals and patent applications is essential.
Karolinska Institutet is one of the world's leading medical universities. Our vision is to pursue the development of knowledge about life and to promote better health for all. At Karolinska Institutet, we conduct innovative medical research and provide the largest range of biomedical education in Sweden. Karolinska Institutet is a state university, which entitles employees to several benefits such as extended holiday and a generous occupational pension. Employees also have free access to our modern gym and receive reimbursements for medical care.
Location: Solna, Biomedicum
An employment application must contain the following documents in English:
Welcome to apply at the latest 28th of September 2021
The application is to be submitted through the Varbi recruitment system. In this recruitment, you will apply with your CV without a personal letter. Instead, you will answer some questions about why you are applying for the job in the application form.
Permanent position is initiated by a six months trial period.
Type of employment | Permanent position |
---|---|
Contract type | Full time |
First day of employment | Immediately/Upon agreement |
Salary | Monthly salary |
Number of positions | 1 |
Full-time equivalent | 100% |
City | Solna |
County | Stockholms län |
Country | Sweden |
Reference number | STÖD 2-4063/2021 |
Contact |
|
Union representative |
|
Published | 17.Sep.2021 |
Last application date | 28.Sep.2021 11:59 PM CEST |